York PhD project P15: New molecular architectures for targeting the mycobacterial respiratory chain

York PhD project P15: New molecular architectures for targeting the mycobacterial respiratory chain

Executive Verdict

How can chemical, functional, cell-level and structural evidence support reliable interpretation of respiratory-targeting drug mechanisms? P15 is a mechanism-focused doctorate; agreement between measurements does not by itself establish therapeutic value.

Programme information identifies P15 as a mechanism-focused tuberculosis project. The official CSHP CDT project list confirms the title, 2027-entry context, York base, supervisors Alison Parkin and Jamie Blaza, and Ineos Oxford Institute (IOI) partnership. The scientific fit is unusually direct: Parkin's programme centres on quantitative bioelectrochemistry of redox-active proteins and bacterial metabolism; Blaza leads work in bacterial bioenergetics, spectroscopy and cryo-EM; and their team has already published a 2025 study using whole-cell spectroscopy to resolve how a respiratory-chain drug changes electron flow in living mycobacteria.

The opportunity is strongest for an applicant who wants to connect chemical structure, enzyme inhibition, cell-level respiratory consequences and structural evidence. It is less suitable for someone seeking a purely synthetic chemistry doctorate, a purely computational project, or a rapid route to clinical translation. The project page names complementary methods but does not disclose the compound portfolio, project-specific facility allocations, validation plan, biological material, sample numbers or fallback thesis route.

For a mainland Chinese applicant, academic application is possible in principle: York publishes country-specific research-degree guidance for China, and UKRI rules permit international students in funded cohorts. Funding is nevertheless the critical unresolved issue. The current CDT FAQ explicitly guarantees full fees and stipend for eligible UK and Irish students, while UKRI normally caps the international share of a funded cohort at 30% and funds tuition only at the home-fee level. The public P15 materials do not state who would pay the overseas-fee difference for a Chinese national in 2027/28. A written full-cost funding schedule is essential before an offer is accepted.

The project also involves a safety question: public sources do not establish whether the student would handle live pathogenic M. tuberculosis, a lower-risk model, purified components, external data or some combination. If work involves hazardous biological agents, it must take place in approved facilities under formal risk assessment, containment, training and supervision; the advert does not specify the student's materials or arrangements.

School, Programme, and Location Signal

P15 belongs to the EPSRC Centre for Doctoral Training in Chemical Synthesis for a Healthy Planet (CSHP CDT), a four-year Oxford-York programme. The CDT's application page describes up to sixteen fully funded studentships each year and requires applicants to apply to the host institution of their preferred projects. The research-project page describes a shared training phase followed by a 44-month substantive research project. P15 is hosted at York, not Oxford, even though IOI is an Oxford-based industrial partner and the cohort trains across both universities.

York Chemistry is a strong environment on current public indicators. The department reports an eighth-place UK Chemistry position in the Complete University Guide 2027. Ranking should not drive a doctoral decision by itself, but it is consistent with the more decision-relevant evidence: an established structural-biology centre, specialised biophysical facilities, active supervisor funding and an externally connected CDT.

The programme model adds both value and constraints. Cohort training, exposure to two universities and industry-linked projects can broaden professional development and reduce dependence on a single research group. Conversely, the first-year training and project-allocation process mean the applicant is joining a programme as well as selecting P15. The CDT FAQ says projects are allocated after interview ranking, with the highest-scoring candidates receiving preferences first. Listing P15 first is therefore not the same as receiving a guaranteed P15 place.

Supervisor and Lab Assessment

Supervisor Research Directions

Alison Parkin's official profile shows a close match to the functional side of P15. Her work uses film electrochemistry to quantify redox reactions in proteins and enzymes and combines functional measurements with structural and spectroscopic information. Her profile explicitly links bacterial energy metabolism, including M. tuberculosis-relevant biology, to the development of new antibiotics. This is strong evidence that bioelectrochemistry is a genuine laboratory capability rather than a generic method added to a project description.

Jamie Blaza's official profile identifies bioenergetics, cryo-EM and bacteriology as core interests and notes that he established cryo-EM at York. His York research-database profile lists an active MRC-funded programme on energy metabolism and antibiotic action in the tuberculosis pathogen through 2028. The overlap with P15 is direct: respiratory flexibility, membrane-bound energy-transducing systems, spectroscopy and structural analysis all sit within his current programme.

The combination is intellectually coherent. Parkin can support quantitative functional interpretation of redox enzymes; Blaza can support respiratory-system biology, spectroscopy and structure. What remains unknown is the operating model: who provides day-to-day supervision, how often the two streams are reviewed together, whether an IOI scientist formally co-supervises, and which technical staff support data collection and interpretation. Those questions matter because the project could otherwise fragment into separate chemical, functional, cell-level and structural work packages.

Recent Important Publications

The most directly relevant paper is the 2025 Nature Communications study, “Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria”. Blaza and collaborators used whole-cell remission spectroscopy to show how inhibition of ATP synthase changes respiratory electron flow and redirects activity within the mycobacterial respiratory network. The paper provides strong evidence that the advertised whole-cell spectroscopy platform is active and can distinguish competing mechanistic explanations. It does not prove that every IOI compound, target or combination in P15 will behave similarly.

The 2025 PNAS paper “Early activation of bioenergetic metabolism powers bacterial spore germination” applies related spectroscopy to respiratory dynamics in a different bacterial system. It supports the team's broader ability to measure and interpret dynamic bioenergetics. Because the organism and biological question differ from tuberculosis, it is evidence of transferable method expertise rather than P15 efficacy.

A 2026 Parkin-associated paper, “Amino acid mediated oxidative activation of multi-walled carbon nanotubes”, addresses electrode-surface chemistry relevant to protein and enzyme film electrochemistry. Its importance for an applicant is methodological: the supervisor's electrochemical toolkit is still developing. It is not a mycobacterial drug study and should not be presented as one.

Together, the publication set supports a current, complementary supervisory team. A sensible interview question is which of these platforms the student is expected to master personally, which measurements are provided by facility or partner specialists, and what constitutes an independent doctoral contribution.

Lab, Resources, and Collaboration Environment

The York Structural Biology Laboratory is a substantial research environment spanning structural biology, chemical biology and method development, with external partnerships and a long institutional record. Its facilities page documents protein-characterisation, spectroscopy, mass-spectrometry, crystallisation, cryo-EM and NMR capabilities. These are credible ecosystem resources for a project that must connect molecular structure with function.

The cryo-EM facility page gives unusually concrete infrastructure evidence: a 200 kV Glacios, direct-electron detection, sample-preparation support, user training, dedicated storage and GPU/HPC processing. This establishes capability, not entitlement. P15's reserved microscope time, staff effort, data-storage allocation, processing support and contingency for difficult samples are not public.

IOI adds a potentially valuable translational bridge. Its TB Grand Challenge describes a multi-stage therapeutic-development network spanning compound discovery, biological evaluation, computational science, later validation and preparation for a clinical pipeline. For P15, the attractive feature is access to chemical matter and a broader decision framework beyond an isolated academic assay. The risk is dependence on partner-controlled compounds, background data and disclosure rules. Applicants should ask which assets are already available to the doctorate, what may be published, and whether enough independent work remains if a lead series changes or is withdrawn.

Research Direction and Field Outlook

Field Momentum

The public-health case is strong. The WHO Global Tuberculosis Report 2025 estimates that 10.7 million people developed TB and 1.23 million died in 2024, while drug-resistant TB remained a major crisis. These figures support continued investment in new treatment mechanisms. They do not validate a particular compound or combination.

Respiratory flexibility is an important target because the bacterium can redistribute energy-transducing activity under drug pressure. P15's central academic value is therefore not merely “finding another inhibitor.” It is determining when chemical structure produces target-level inhibition, how that perturbation is expressed across the respiratory system, and whether combinations close compensatory routes. The conceptual challenge is to separate direct target engagement from downstream stress responses and to distinguish a promising mechanistic explanation from a therapeutically meaningful effect.

The strongest project design would use an explicit evidence ladder: define what counts as target-level evidence, what independent information is needed to connect that target effect to respiratory consequences, and what additional validation is required before a combination is treated as more than an interesting laboratory interaction. That ladder should also define how contradictory and negative results are retained. This is a scientific-design recommendation, not an experimental protocol.

Potential Research Angles

At applicant-decision level, four thesis angles appear defensible:

1. Relate families of IOI-developed molecular architectures to clearly defined respiratory mechanisms, while quantifying uncertainty rather than forcing every compound into one model.
2. Determine when functional, whole-cell and structural evidence agree and when they diverge, using discordance as a source of biological insight rather than a failed result.
3. Identify principled boundaries for combination claims: mechanistic complementarity, reproducibility and selectivity should be distinguished from clinical promise.
4. Develop a durable decision framework for advancing or stopping respiratory-targeting chemical series, so that the thesis retains value even if no compound progresses. These angles need narrowing. The project page does not publish the number of chemical series, respiratory components, structural targets or validation stages. A candidate should ask for a realistic first-year question, the minimum publishable unit and a fallback route that does not depend on one compound, one structure or one partner decision.

Career and Market Outlook

The training can support careers in academic bacterial bioenergetics, structural biology, quantitative biophysics, antimicrobial discovery, pharmaceutical mechanism-of-action research and scientific platform development. The UK Life Sciences Jobs Plan projects about 66,000 additional priority-sector jobs between 2025 and 2035 and emphasises demand for highly skilled workers. This is a broad labour-market signal, not a promise of employment.

The most portable outputs would be rigorous mechanistic reasoning, quantitative data analysis, structural interpretation, reproducible research practice, cross-disciplinary communication and experience working under industrial, biosafety and IP constraints. A student should seek authorship and ownership of an identifiable research question rather than becoming only a service user of several sophisticated platforms.

Funding, Application, and Living Cost

The first application deadline is Friday 13 November 2026 at 12 noon; the project advert does not state a time zone. The application page says applicants apply directly to the host institution of their preferred projects and list three project choices. The FAQ separately lists a 6 January deadline but does not state its year or whether it applies to P15. Some projects may fill after the first round. Later applications do not establish that P15 is currently available.

The project material does not state an exact start date or an English-language score requirement; confirm both with the host department. The FAQ describes online interviews and project allocation after interview ranking, but the P15 interview schedule is not specified.

York recruitment information asks for a 1,000-word personal statement ending with 1–2–3 ranked project choices, transcripts and two academic/professional referee contacts; York applicants also complete the CSHP EDI form. The application guidance also mentions referee submissions; confirm the current portal requirements. The FAQ says no full research proposal is required for York applicants. Assessment gives equal weight to academic record, references, and motivation/aptitude for the CDT. Interviews are online and include a technical panel plus meetings with prospective supervisors. Applicants should prepare to explain one prior research project, interpret a supplied paper and reason across chemistry and biology without overstating conclusions.

China eligibility must be separated from funding:

• Admission: York's China guidance welcomes applicants from China and says a research degree normally requires a bachelor's degree plus a relevant master's degree or research experience. The recruitment guidance requires an obtained or expected minimum UK 2:1 honours degree or international equivalent in a relevant subject, plus research enthusiasm, independent thinking and work, excellent analytical skills and strong verbal/written communication.
• UKRI international eligibility: UKRI's EPSRC CDT rules allow international students but normally cap them at 30% of the UKRI-funded cohort.
• Public CDT commitment: the current FAQ explicitly describes full course fees and a stipend for eligible UK and Irish candidates. York's prior CSHP funding page stated that the 2026/27 competition was open to international students but listed tuition support at the UK-fee rate. That historical page is not proof of the 2027/28 P15 package.
• Unresolved overseas-fee difference: York publishes separate home and international research-fee schedules on its fees page. The P15 page does not say whether York, the CDT, IOI or another source covers the international difference. A Chinese applicant should not interpret “fully funded” as confirmed full overseas funding until the award letter itemises it. The public stipend figure is £21,805 per year for 2026/27; the 2027/28 rate is not yet confirmed on the reviewed pages. Housing is the largest cost. As a concrete stress test, Wentworth Graduate College lists 2026/27 postgraduate 51-week rooms at £10,506-£11,424. That would consume roughly 48-52% of the cited stipend before food, utilities, local travel, visa costs, the immigration health surcharge and travel from China. York's living-cost guide recommends an individual budget and inflation allowance.

Before acceptance, obtain a written four-year schedule covering overseas tuition, stipend and annual uplift, required Oxford-York travel, research expenses, facility costs, conference travel, visa-related support and any writing-up period. If any overseas-fee gap remains, calculate it across all four years with fee inflation rather than only the first year.

Applicant Fit and Preparation

Best suited for

• Applicants with strong chemistry, chemical biology, biochemistry, biophysics, structural biology or closely related training and evidence of quantitative reasoning.
• Candidates who can connect molecular structure to mechanism without treating one measurement as proof of a therapeutic claim.
• Applicants comfortable learning across electrochemistry, spectroscopy, structural analysis and bacterial bioenergetics at a conceptual and analytical level.
• Researchers who value negative results, reproducibility and independent validation.
• Candidates willing to work under strict biosafety, data, confidentiality and publication governance.

May need caution if

• Full overseas-fee funding is essential and no written P15-specific confirmation has been obtained.
• The applicant wants a purely synthetic, purely computational or purely structural doctorate.
• The applicant expects the project to guarantee clinical translation or a successful antibiotic combination.
• The applicant is uncomfortable with partner-controlled chemical matter, potential patent review or temporary publication delay.
• The applicant cannot commit to safety training and approved containment requirements if their assigned work package involves hazardous biological agents.

Skills and evidence to strengthen

The personal statement should show one or two examples of careful research judgement. Explain the question, the evidence collected, a quality or interpretation problem, how the conclusion changed and what remained uncertain. Relevant evidence could come from quantitative chemistry, protein or membrane biochemistry, spectroscopy, electrochemistry, structural biology, antimicrobial research, data analysis or another rigorous experimental setting.

Applicants from outside synthetic chemistry should directly address the CDT's synthesis emphasis and ask how much compound synthesis versus mechanistic characterisation P15 expects. Applicants with primarily synthetic training should demonstrate readiness for quantitative biological interpretation. A concise discussion of how to distinguish target engagement, system response and translational evidence will be stronger than listing instruments.

The application should remain at scientific-decision level. It should not include pathogen culture conditions, detailed biological procedures, parameter sets or a proposed operational workflow. The supervisors can assess technical training needs within the approved institutional safety framework.

Risks and Questions to Verify

High-priority questions

1. For a mainland Chinese national, does the 2027/28 P15 studentship cover the full international tuition fee for all four years, and which organisation pays any overseas-fee difference?
2. How many international awards are available in the cohort under the 30% cap, and is international funding decided centrally or per host institution?
3. What are the confirmed 2027/28 stipend, annual uplift, research budget, mandatory travel coverage and support for visa or immigration-health costs?
4. Is P15 still available in the current round, and does listing it first provide any project-specific assessment before the central interview ranking?
5. Which IOI compound series, background data and partner staff support are committed to the project, and what happens if priorities or access change?
6. What is the bounded first-year research question, the expected thesis-sized scope, the independent validation standard and the fallback route if a major compound or structural objective fails?
7. Which named York facilities, instrument time, storage, compute, consumables and technical support are already budgeted for P15?
8. What biological material would the student handle, which approved facility would host each work package, and what risk assessment, containment, training, registration and occupational-health requirements apply?
9. What is the Parkin-Blaza-IOI supervision split, who provides day-to-day mentoring and how often are chemical, functional, cell-level and structural evidence reviewed together?
10. What project-specific agreement governs background IP, new IP, data ownership, compound confidentiality, authorship, patent review, publication delay and thesis embargo?

Medium-priority questions

1. Which measurements are expected to be performed independently by the student and which are delivered collaboratively by facilities or partners?
2. How are negative, inactive or mechanistically discordant results preserved and made publishable?
3. What controls the transition from a mechanism claim to a combination claim, and which claims remain outside the doctorate's scope?
4. Are any external visits or placements expected at Oxford or partner sites, and are travel, accommodation, visa and insurance fully covered?
5. What data-management plan applies to structural, spectroscopic and partner-generated data, and what can be deposited openly at the end of the project?
6. What training is available for quantitative analysis, research software, statistics, responsible innovation and communication across disciplines? York's biological-safety framework requires formal risk assessment, approval, local rules and training for hazardous biological agents, with additional requirements for higher containment. National HSE guidance defines hazard groups and formal notification or consent requirements for deliberate higher-risk work. These controls are material applicant questions, not procedural details. The project should state clearly which work the student is authorised and trained to undertake.

Data and commercial terms also require written clarification. York's Regulation 12 says third-party studentship agreements can govern ownership and exploitation of student-created IP, and it permits temporary publication delay in commercially sensitive cases. The Research Data Management Policy requires postgraduate researchers to handle ownership, preservation, sharing, privacy, security and contractual restrictions through sound data planning. General policies are not substitutes for the P15 agreement.

Evidence and Sources

The project and programme sources support a mechanism-focused scope, a York host and an Oxford-York training route. The cited papers address distinct contexts: mycobacterial respiratory-chain action, bioenergetics in another bacterial system and electrode-surface chemistry. They provide complementary methodological context, not proof that every method or compound is part of P15. Institutional facilities demonstrate capability, not project allocation.

Project, programme, application and funding

• Official P15 project entry and 2027 project list
• CSHP CDT application process
• CSHP admissions, interviews, allocation and funding FAQ
• York CSHP funding page for 2026/27 context
• EPSRC CDT rules and international-student cap
• York entry guidance for applicants from China
• York postgraduate research fees
• York postgraduate living-cost guide
• Wentworth Graduate College 2026/27 prices

Supervisors, facilities and collaboration

• Alison Parkin profile
• Jamie Blaza profile
• Jamie Blaza research record
• York Structural Biology Laboratory
• YSBL facilities
• York cryo-EM facility
• IOI Tuberculosis Grand Challenge

Publications, field and career evidence

• 2025 mycobacterial bedaquiline mechanism paper
• 2025 bacterial bioenergetics paper
• 2026 protein-film electrochemistry method paper
• WHO Global Tuberculosis Report 2025
• UK Life Sciences Jobs Plan

Safety, data and IP governance

• York biological-safety framework
• HSE deliberate-work guidance for biological agents
• York intellectual-property regulation
• York Research Data Management Policy